APP and Alzheimer disease: Second, COX-2 overexpression induces alteration of the neuronal cell cycle in APP/PS1 Tg mice, which provides a rational basis for targeting neuronal COX-2 in therapeutic research aimed at slowing the clinical progression of AD (Xiang et al., 2002).